Experimental drug targets debilitating 'Brain Fog' in lupus patients
Disease control
Completed
This study tested whether a drug called EG-501 could improve thinking and memory problems, often called 'brain fog,' in people with lupus. 131 adults with lupus and confirmed cognitive impairment were randomly assigned to receive either EG-501 or a placebo (inactive substance) fo…
Phase: PHASE2 • Sponsor: Evergreen Therapeutics, Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC